1. Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy
   Alicja Rajtak et al, 2022, Frontiers in Immunology CrossRef
2. Accuracy of CCL20 expression level as a liquid biopsy-based diagnostic biomarker for ovarian carcinoma
   Watchara Sakares et al, 2022, Frontiers in Oncology CrossRef
3. Identification of CXCL10-Relevant Tumor Microenvironment Characterization and Clinical Outcome in Ovarian Cancer
   Jing Jin et al, 2021, Frontiers in Genetics CrossRef
4. SNHG22 overexpression indicates poor prognosis and induces chemotherapy resistance via the miR-2467/Gal-1 signaling pathway in epithelial ovarian carcinoma
   Peng-Fei Zhang et al, 2019, Aging CrossRef
5. SAMHD1 expression modulates innate immune activation and correlates with ovarian cancer prognosis
   Lucía Gutiérrez-Chamorro et al, 2023, Frontiers in Immunology CrossRef
6. Techniques for Profiling the Cellular Immune Response and Their Implications for Interventional Oncology
   Tushar Garg et al, 2022, Cancers CrossRef
7. Active Ratio Test (ART) as a Novel Diagnostic for Ovarian Cancer
   Sung-Woog Kang et al, 2021, Diagnostics CrossRef